IP Basics

Converse, Inc. v. ITC

Tiffany & Co. and Christian Louboutin warned the Federal Circuit that an International Trade Commission’s decision revoking trade dress protection for the design of Converse’s Chuck Taylor sneaker “threatens to upset the current equilibrium in trademark law.” The suits, filed in both federal court and the U.S. International Trade Commission, didn't target just no-name companies: [...]

By |2017-09-08T12:29:57+05:30March 9th, 2017|Patent, IP Basics|0 Comments

IP Infringement in India

Intellectual property Infringement is basically using someone else’s Intellectual property without the permission of the owner of those Intellectual Property holders who has the rights. Infringement is “a crime less serious than a felony”. Intellectual property infringement could be anything’s that relates to the intellectual property it can be trademark infringement copyright infringement, patent [...]

By |2017-09-08T12:35:11+05:30March 8th, 2017|IP Basics|0 Comments

Help C Drug Pricing: Sofosbuvir Unaffordable

Imagine waking up on the wrong side of the bed. Your skin looks yellow and you start feeling blue. Abdominal pains make you cringe, despite never having binged. The family doctor rules out jaundice and draws a blank. Your hospital-next-door churns out the blood report and you anxiously gaze into the diagnosis: “Tested positive [...]

By |2017-09-08T12:36:03+05:30March 7th, 2017|IP Basics|0 Comments

Rice & IP: The Green Rice Mystery

Over the last year with the Monsanto-Nuziveedu dispute, India has witnessed one of its biggest IP disputes in the agricultural sector. The Basmati GI dispute also has huge implication but as I’m reminded, often, by several people, geographical indications (GI) do not qualify as IP. These disputes aside, we’ve also come across two other [...]

By |2017-09-08T12:37:04+05:30March 7th, 2017|IP Basics, Patent|0 Comments

Bayer v. Ajanta: DHC Erects New Jurisprudence on Public Interest for Injunctions

On 20 December 2016, Justice RK Gauba of the Delhi High Court heard an interlocutory application under Order 39 Rules 1 and 2 of the CPC filed by Bayer Intellectual Property GmbH in a suit concerning IN225529(3275/DEL/1998) against Ajanta Pharma Ltd. Bayer asserted that the patent covered vardenafil, a drug used to treat erectile dysfunction, and [...]

By |2017-09-08T12:38:59+05:30March 6th, 2017|IP Basics, Patent|0 Comments

Death trolls by Litchi Fruit: Misappropriation of ISR

The Indian government issued a statement Wednesday advising children to henceforth “minimize litchi fruit consumption” in affected areas, and eats an evening meal during the "outbreak period." In a development that raises a number of profound and fundamental questions about the phenomenon of Indian science research being misappropriated without proper attribution, a study recently published in [...]

By |2017-09-08T12:39:35+05:30March 6th, 2017|IP Basics|0 Comments
Go to Top